Results 111 to 120 of about 166,081,157 (256)
This study simultaneously investigated circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients. The elevated expression of JUNB and CXCR4 in CTCs was a poor prognostic factor for SCLC patients, whereas exosomal overexpression of these biomarkers revealed a high discrimination ability of patients from healthy individuals,
Dimitrios Papakonstantinou+13 more
wiley +1 more source
The Opiate Antagonist Naloxone Counteracts the Inhibition of Sympathetic Nerve Activity Caused by Halothane Anesthesia in Rats [PDF]
Martin Delle+2 more
openalex +1 more source
This study explores how sepsis affects GC progression by creating an immunosuppressive environment. Our findings reveal that sepsis promotes immune dysregulation, enhancing tumor growth and metastasis. Targeting the PD‐1/PD‐L1 pathway with monoclonal antibodies shows potential for restoring immune function and improving outcomes in cancer patients ...
Yiding Wang+10 more
wiley +1 more source
VASP was found to be overexpressed in metastatic oral squamous cell carcinoma (OSCC) tissues. Notably, PTTG1‐ and VASP‐deficient OSCC cells demonstrated suppressed metastatic properties by disrupting the interaction between the cytoskeleton and focal adhesion (FAs) in the filopodia region.
Suyeon Park+6 more
wiley +1 more source
Antagonism by naloxone (N) of tolerance (T) and dependence (D) in mice treated with morphine (M)
Ichiro Yano, Tadashi MURANO
openalex +1 more source
Acute Pulmonary Edema in Healthy Teenagers Following Conservative Doses of Intravenous Naloxone [PDF]
Donald S. Prough+3 more
openalex +1 more source
Consensus molecular subtypes (CMS1‐4) have been identified to study colorectal cancer heterogeneity and serve as potential biomarkers. In this study, we developed and evaluated NanoCMSer, a NanoString‐based classifier using 55 genes, optimized for FF and FFPE to facilitate the clinical evaluation of CMS subtyping.
Arezo Torang+10 more
wiley +1 more source
A double blind trial of naloxone in the treatment of acute stroke. [PDF]
Richard Fallis+2 more
openalex +1 more source